NO924857L - 17-spirofuran-3'-yliden-steroider - Google Patents
17-spirofuran-3'-yliden-steroiderInfo
- Publication number
- NO924857L NO924857L NO92924857A NO924857A NO924857L NO 924857 L NO924857 L NO 924857L NO 92924857 A NO92924857 A NO 92924857A NO 924857 A NO924857 A NO 924857A NO 924857 L NO924857 L NO 924857L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- spirofuran
- hydrogen
- ylidene
- steroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91203366 | 1991-12-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO924857D0 NO924857D0 (no) | 1992-12-15 |
NO924857L true NO924857L (no) | 1993-06-21 |
NO302525B1 NO302525B1 (no) | 1998-03-16 |
Family
ID=8208088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO924857A NO302525B1 (no) | 1991-12-20 | 1992-12-15 | 17-spirofuran-3'-yliden-steroider |
Country Status (17)
Country | Link |
---|---|
US (1) | US5292878A (no) |
EP (1) | EP0549041B1 (no) |
JP (1) | JP3462515B2 (no) |
KR (1) | KR100287513B1 (no) |
AT (1) | ATE128983T1 (no) |
AU (1) | AU655858B2 (no) |
CA (1) | CA2084431C (no) |
DE (1) | DE69205405T2 (no) |
DK (1) | DK0549041T3 (no) |
ES (1) | ES2081040T3 (no) |
FI (1) | FI104178B1 (no) |
GR (1) | GR3018630T3 (no) |
HK (1) | HK1002033A1 (no) |
MX (1) | MX9207394A (no) |
NO (1) | NO302525B1 (no) |
NZ (1) | NZ245520A (no) |
ZA (1) | ZA929315B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2100514C (en) * | 1992-07-29 | 2005-03-29 | Johannes A. M. Hamersma | 17-spiromethylene steroids |
NZ504351A (en) * | 1997-11-14 | 2002-10-25 | Akzo Nobel Nv | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen |
US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
ATE473759T1 (de) | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US5962444A (en) * | 1998-05-29 | 1999-10-05 | Research Triangle Institute | 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
EP1178807B1 (en) * | 1999-04-29 | 2004-09-29 | Akzo Nobel N.V. | Use of org 33245 in combined intermittent hormone therapy and contraception |
US6043235A (en) * | 1999-07-21 | 2000-03-28 | Research Triangle Institute | 11β-aryl-17, 17-spirothiolane-substituted steroids |
US7426602B2 (en) * | 2004-01-08 | 2008-09-16 | Topside Research, Llc | Switch for bus optimization |
TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
AU2007217094A1 (en) * | 2006-02-17 | 2007-08-30 | Janssen Pharmaceutica N.V. | 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
DK1989218T3 (da) * | 2006-02-17 | 2010-04-26 | Janssen Pharmaceutica Nv | 17-phosphor-steroidderivater, der er anvendelige som progesteronreceptormodulatorer |
EP3693376A1 (en) | 2006-10-24 | 2020-08-12 | Allergan Pharmaceuticals International Limited | Compositions for suppressing endometrial proliferation |
TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
US8673968B2 (en) * | 2009-04-06 | 2014-03-18 | Evestra, Inc. | Progesterone antagonists |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
CN101926806A (zh) * | 2009-06-24 | 2010-12-29 | 天津金耀集团有限公司 | 一种17磷类雌甾化合物在制备紧急避孕药物中的应用 |
EP2550288A1 (en) | 2010-03-22 | 2013-01-30 | Repros Therapeutics Inc. | Compositions and methods for non-toxic delivery of antiprogestins |
US20130272956A1 (en) * | 2010-06-17 | 2013-10-17 | Franciscus Theodorus Leonardus Brands | (11beta, 17alpha)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY-19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE |
US9096641B2 (en) | 2013-06-05 | 2015-08-04 | Evestra, Inc. | Imidazolyl progesterone antagonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3461090D1 (en) * | 1983-02-18 | 1986-12-04 | Schering Ag | 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them |
FR2596395B1 (fr) * | 1986-03-26 | 1989-05-26 | Roussel Uclaf | Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
DE3761308D1 (de) * | 1986-07-23 | 1990-02-08 | Akzo Nv | 18-phenylestrane-derivate. |
IE60780B1 (en) * | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
DE3866410D1 (de) * | 1987-04-24 | 1992-01-09 | Akzo Nv | 11-arylestranderivate und 11-arylpregnanderivate. |
ES2053714T3 (es) * | 1987-12-12 | 1994-08-01 | Akzo Nv | Proceso para la preparacion de 11-arilesteroides. |
-
1992
- 1992-12-01 ZA ZA929315A patent/ZA929315B/xx unknown
- 1992-12-03 CA CA002084431A patent/CA2084431C/en not_active Expired - Fee Related
- 1992-12-11 AU AU30093/92A patent/AU655858B2/en not_active Ceased
- 1992-12-15 DE DE69205405T patent/DE69205405T2/de not_active Expired - Fee Related
- 1992-12-15 AT AT92203923T patent/ATE128983T1/de not_active IP Right Cessation
- 1992-12-15 EP EP92203923A patent/EP0549041B1/en not_active Expired - Lifetime
- 1992-12-15 ES ES92203923T patent/ES2081040T3/es not_active Expired - Lifetime
- 1992-12-15 DK DK92203923.5T patent/DK0549041T3/da active
- 1992-12-15 NO NO924857A patent/NO302525B1/no unknown
- 1992-12-17 MX MX9207394A patent/MX9207394A/es not_active IP Right Cessation
- 1992-12-17 KR KR1019920024581A patent/KR100287513B1/ko not_active IP Right Cessation
- 1992-12-18 FI FI925790A patent/FI104178B1/fi active
- 1992-12-18 JP JP33883092A patent/JP3462515B2/ja not_active Expired - Fee Related
- 1992-12-18 NZ NZ245520A patent/NZ245520A/en unknown
- 1992-12-21 US US07/994,039 patent/US5292878A/en not_active Expired - Lifetime
-
1996
- 1996-01-10 GR GR960400050T patent/GR3018630T3/el unknown
-
1998
- 1998-02-11 HK HK98101028A patent/HK1002033A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0549041B1 (en) | 1995-10-11 |
FI104178B (fi) | 1999-11-30 |
NZ245520A (en) | 1995-02-24 |
CA2084431A1 (en) | 1993-06-21 |
HK1002033A1 (en) | 1998-07-24 |
KR100287513B1 (ko) | 2001-05-02 |
ES2081040T3 (es) | 1996-02-16 |
GR3018630T3 (en) | 1996-04-30 |
FI104178B1 (fi) | 1999-11-30 |
CA2084431C (en) | 2003-04-08 |
ZA929315B (en) | 1993-05-24 |
FI925790A (fi) | 1993-06-21 |
EP0549041A1 (en) | 1993-06-30 |
JP3462515B2 (ja) | 2003-11-05 |
JPH05255380A (ja) | 1993-10-05 |
NO924857D0 (no) | 1992-12-15 |
AU655858B2 (en) | 1995-01-12 |
MX9207394A (es) | 1993-07-30 |
NO302525B1 (no) | 1998-03-16 |
DE69205405D1 (de) | 1995-11-16 |
ATE128983T1 (de) | 1995-10-15 |
DK0549041T3 (da) | 1996-01-29 |
FI925790A0 (fi) | 1992-12-18 |
DE69205405T2 (de) | 1996-05-09 |
AU3009392A (en) | 1993-06-24 |
US5292878A (en) | 1994-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI104178B1 (fi) | 17-spirofuran-3'-ylideenisteroidit | |
ATE176237T1 (de) | Sphingoglycolipid und verwendung davon | |
BR1100621A (pt) | Compostos | |
FI955108A (fi) | Steroideja, jotka sisältävät 17-spiromtyleenilaktoni- tai laktoliryhmän | |
NO940777D0 (no) | Anvendelse av et pregnanderivat | |
DE69717895D1 (de) | Diagnostisches Mittel zur Glykostoffwechselfunktion | |
ZA907639B (en) | Benzanilides | |
FI823458A0 (fi) | Substituerade tiazolidinylestrar av mineralsyror | |
FR2501676B1 (no) | ||
ATE72445T1 (de) | 4'-epi-4'-aminoanthracycline. | |
ES2068407T3 (es) | Tratamiento de apneas durante el sueño con derivados de azapirona. | |
IL117497A (en) | 17-difluoromethylene estratriene derivatives and pharmaceutical compositions containing the same | |
ATE73136T1 (de) | Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate. | |
ES463228A1 (es) | Procedimiento para preparar quinolinonas | |
ES2070376T3 (es) | 2-aciloxi-4-morfolinil antraciclina. | |
FI812777L (fi) | Foerfarande foer framstaellning av nya cardenolid-bis-digitoxosider | |
DE69615814D1 (de) | Uch-15-verbindungen |